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Abstract
Background Lewy body dementia (LBD) and Alzheimer’s disease (AD) are common forms of degenerative dementia. While 
they are characterized by different clinical profiles, attentional deficits are a common feature. The objective of this study was 
to investigate how attentional problems in LBD and AD differentially affect different aspects of reaction time performance 
and to identify possible structural neural correlates.
Methods We studied reaction time data from an attention task comparing 39 LBD patients, 28 AD patients, and 22 age-
matched healthy controls. Data were fitted to an ex-Gaussian model to characterize different facets of the reaction time dis-
tribution (mean reaction time, reaction time variability, and the subset of extremely slow responses). Correlations between 
ex-Gaussian parameters and grey and white matter volume were assessed by voxel-based morphometry.
Results Both dementia groups showed an increase in extremely slow responses. While there was no difference between AD 
and controls with respect to mean reaction time and variability, both were significantly increased in LBD patients compared 
to controls and AD. There were widespread correlations between mean reaction time and variability and grey matter loss 
in AD, but not in LBD.
Conclusions This study shows that different aspects of reaction time performance are differentially affected by AD and 
LBD, with a difference in structural neural correlates underlying the observed behavioural deficits. While impaired atten-
tional performance is linked to brain atrophy in AD, in LBD it might be related to functional or microstructural rather than 
macrostructural changes.
Keywords Attention network test · Cognitive fluctuations · Voxel-based morphometry · Parkinsonism · Neurodegeneration
Introduction
Lewy body dementia (LBD), which includes both dementia 
with Lewy bodies (DLB) and Parkinson’s disease dementia 
(PDD), represents the second to third most common form of 
neurodegenerative dementia in older age after Alzheimer’s 
disease (AD) [1]. DLB and PDD show a similar clinical 
profile characterized by complex visual hallucinations, cog-
nitive fluctuations, and Parkinsonian motor symptoms [2, 3] 
and are only differentiated by whether the cognitive or the 
motor symptoms occur first [4].
Attentional and executive deficits occur frequently in 
both AD and LBD [5]. Reaction times have been shown to 
be increased and more variable in patients with dementia 
in general, and LBD patients show slower reaction times 
and higher intraindividual variability than AD patients [6, 
7]. This difference increases with increasing task demand, 
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especially when the task involves an executive or spatial 
aspect [7]. Additionally, LBD patients with more marked 
cognitive fluctuations have slower reaction times, impaired 
vigilance and higher fluctuations in reaction time perfor-
mance compared to those patients with less severe fluctua-
tions [8–10].
A large majority of reaction time studies focus on analys-
ing mean reaction times. However, reaction times are usually 
not normally distributed, but positively skewed. Describing 
this distribution by more than central tendency measures, 
therefore, provides a more detailed and accurate analysis 
method [11]. One distribution that has been used success-
fully to model empirical reaction times is the exponentially 
modified Gaussian (ex-Gaussian) distribution. This is a con-
volution of a Gaussian and an exponential distribution char-
acterized by three parameters—mu, sigma, and tau—that 
describe different aspects of the ex-Gaussian distribution. 
Mu and sigma describe the mean and standard deviation 
of the Gaussian part, respectively, while tau quantifies the 
right tail of the distribution which describes the subset of 
extremely slow responses [12]. The ex-Gaussian analysis, 
therefore, allows investigation of the effect of ageing and 
dementia on different aspects of reaction time distributions. 
An overall shift of the distribution to higher or lower val-
ues will be primarily reflected by a change in mu, whereas 
changes in skewness will be indicated by a change in tau. 
While ageing has been shown to affect all three parame-
ters, AD only affects the tau component compared to age-
matched controls without dementia [13, 14].
Even though attentional dysfunction is a core feature of 
LBD, no previous study has analysed reaction times in LBD 
with an ex-Gaussian analysis. The first aim of the present 
study is, therefore, to investigate how different aspects of 
reaction times as modelled by the ex-Gaussian distribu-
tion are differentially affected in LBD compared to AD 
and healthy ageing. Based on previous studies, we hypoth-
esized to see an increase in tau in the AD group compared to 
healthy controls with little change in mu and sigma [13, 14]. 
Given that attentional impairment is more pronounced in 
LBD than in AD, we expected to see an increase in all three 
ex-Gaussian parameters in LBD compared to controls and 
AD. Tau represents the subset of extremely slow responses 
and, therefore, specifically captures lapses in attention or 
attentional fluctuations [15]. Since fluctuations in attention 
are a core symptom of LBD and less common in AD [16], 
we hypothesized to see a specific increase in tau in the LBD 
group compared to AD.
A second aim of this study is to investigate the relation-
ship between the different ex-Gaussian parameters and 
clinical scores in the LBD group, especially with respect to 
cognitive fluctuations. The clinical identification of cogni-
tive fluctuations can often be challenging and different stud-
ies have underscored the need for more objective markers 
of fluctuations in LBD [10, 17, 18]. Given the association 
between tau and attentional fluctuations [15] and evidence 
from previous studies for a link between cognitive fluctua-
tions and reaction time variability [8–10], we investigated 
tau as a potential candidate for such an objective marker of 
fluctuations in LBD.
Previous studies have suggested an association between 
reaction time deficits and structural brain abnormalities in 
AD [13]. The third aim of this study is, therefore, to inves-
tigate possible macrostructural neural correlates of reaction 
time deficits in AD and LBD. This was done by analysing 
voxelwise relations between the three ex-Gaussian param-
eters and grey and white matter volume in both dementia 
groups.
Methods
Participants
The study involved 103 participants who were over 60 years 
of age. Patients were recruited from the local community-
dwelling population who had been referred to old age psy-
chiatry and neurology services. The study was approved 
by the local ethics committee. Forty-eight participants 
were diagnosed with probable LBD (26 DLB and 22 PDD 
patients), 33 with probable AD, and 22 were age-matched 
healthy controls (HC) with no history of psychiatric or neu-
rological illness. Clinical diagnoses were performed inde-
pendently by two experienced old age psychiatrists in align-
ment with consensus criteria for probable DLB [2], PDD 
[19], and AD [20]. To aid clinical diagnosis, DAT-scans 
were performed in a subset of the DLB patients [21, 22].
Modified attention network test
We used a modified version of the attention network test 
(ANT) [23, 24] based on the version described by Fan et al. 
[25]. The main rationale for adapting the ANT was to make 
it suitable for older adults and dementia patients. This was 
achieved by increasing the size of the stimuli to account for 
participants with poor visual acuity and by adjusting the 
timings to account for slower cognitive processing speed in 
older adults [26]. A detailed description of the task can be 
found in Ref. [24]. Briefly, the ANT combines elements of 
the Erikson flanker task [27] and the Posner cueing paradigm 
[28] to form a single visual reaction time task. There are 
three different cue conditions: no cue, neutral cue, or spatial 
cue. This is followed by a flanker task during which, in our 
modified ANT, participants are asked to decide upon the 
majority direction of four arrows. The arrows either all point 
to the same direction (congruent target) or one arrow points 
to the opposite direction (incongruent target). Participants 
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completed between 6 and 10 (median = 8) runs of the task, 
each run comprising 36 trials. All trials from runs with less 
than 2/3 correct responses were excluded from the analysis 
as performance below this was not different from chance 
[23]. Additionally, participants with less than 70 remaining 
correct trials were excluded to allow a robust fit of the ex-
Gaussian distribution.
Ex‑Gaussian analysis
Response times from the ANT were analysed by fitting an 
ex-Gaussian distribution to the response times from all cor-
rect trials for each participant individually (combining all 
cue and target conditions). The ex-Gaussian distribution is 
a convolution of a Gaussian and an exponential distribution 
and can be described by three parameters. Mu and sigma 
represent the mean and standard deviation of the Gauss-
ian component, respectively. Tau is the decay parameter of 
the exponential component and characterizes the slow tail 
of the distribution (see Fig. 1). Ex-Gaussian parameters for 
each participant were estimated using the DISTRIB toolbox 
in Matlab (R2015b) which applies a maximum likelihood 
approach with a bounded search [29].
VBM analysis
Structural images were acquired on a 3 T Philips Intera 
Achieva scanner with a magnetization prepared rapid gra-
dient echo (MPRAGE) sequence, sagittal acquisition, echo 
time 4.6 ms, repetition time 8.3 ms, inversion time 1250 ms, 
flip angle = 8°, SENSE factor = 2, and in-plane field of view 
240 × 240 mm2 with slice thickness 1.0 mm, yielding a voxel 
size of 1.0 × 1.0 × 1.0 mm3.
A voxel-based morphometry (VBM) analysis was per-
formed in SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) to 
assess voxelwise correlations between the ex-Gaussian 
parameters and cortical volume. This analysis was per-
formed separately in the AD and LBD groups. First, images 
were segmented into grey matter, white matter, and cerebro-
spinal fluid. The segmented grey and white matter images 
were then coregistered and normalized to MNI space using 
SPM’s DARTEL algorithm [30] and modulated. As a final 
step, images were smoothed with an 8 mm full width at half 
maximum Gaussian kernel. Using these images, correlations 
between grey and white matter volume and the ex-Gaussian 
parameters were assessed using multiple regression in SPM 
for each ex-Gaussian parameter separately. Covariates of no 
interest for age, gender, and total intracranial volume were 
included in the design matrix. The UPDRS motor score 
was included as an additional covariate in the LBD group. 
An explicit mask was estimated using the SPM Masking 
Toolbox [31] to restrict the statistical analysis to voxels that 
represent grey and white matter, respectively. An uncor-
rected voxel-level threshold of p < 0.001 was chosen. Sub-
sequently, the minimum cluster size for a corrected threshold 
of p < 0.05 was determined using the 3dClustSim function 
in AFNI (https ://afni.nimh.nih.gov).
Statistics
Statistical analyses were carried out in IBM SPSS Statistics 
version 22. Kolmogorov–Smirnov normality tests indicated 
Fig. 1  a Ex-Gaussian function 
as a convolution of a Gaussian 
function with mean mu and 
standard deviation sigma and an 
exponential function with decay 
parameter tau. b Example fit of 
the ex-Gaussian function to an 
empirical reaction time (RT) 
distribution
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that the ex-Gaussian parameters were not normally distrib-
uted in all clinical groups (p < 0.05). Therefore, the three 
ex-Gaussian parameters were compared between the groups 
by a non-parametric Kruskal–Wallis ANOVA and post 
hoc Dunn’s tests with Bonferroni correction. Correlations 
between the ex-Gaussian parameters and different clinical 
scores were assessed by Spearman’s rank correlations and p 
values were FDR corrected for multiple comparisons.
Results
Demographics
Five AD, three DLB, and six PDD patients were excluded 
because they did not fulfil the reaction time performance 
criteria (see “Modified attention network test” section). This 
resulted in 28 AD, 39 LBD (23 DLB and 16 PDD), and 22 
HC participants for further analysis.
Demographic and clinical information for all included 
participants is presented in Table 1. All three groups were 
matched for age and gender. As expected, the LBD group 
had more frequent occurrence of the core LBD symp-
toms (cognitive fluctuations, visual hallucinations, and 
Parkinsonism) than the AD group. However, they were 
slightly less impaired in terms of overall cognition (MMSE 
and CAMCOG) and the time since the onset of cognitive 
symptoms was shorter in the LBD group compared to the 
AD group. To ensure that group differences in overall 
cognition did not influence the results, all analyses were 
repeated on AD and LBD subgroups that were matched for 
overall cognition (see “Comparison of demographics and 
clinical variables for matched AD and LBD subgroups” 
section of the Supplementary Material). The percentage 
of patients taking cholinesterase inhibitors did not differ 
between the two dementia groups whereas significantly 
more LBD patients were taking dopaminergic medication. 
Fourteen DLB patients underwent a DAT-scan; all except 
one of these patients showed an abnormal scan.
It was decided a priori to combine the DLB and PDD 
patients into one Lewy body dementia group as previ-
ous studies have shown similar attentional and execu-
tive impairment in DLB and PDD [9, 23] as well as 
similar brain structural abnormalities [32]. The DLB and 
PDD subgroups were matched in terms of age, overall 
cognition, and dementia duration (see Supplementary 
Table S1). PDD patients were more impaired in terms 
of Parkinsonism, psychiatric symptoms, and cognitive 
Table 1  Demographics and 
clinical information, mean 
(standard deviation)
AChEI number of patients taking acetylcholinesterase inhibitors, AD Alzheimer’s disease, CAF total Clini-
cal Assessment of Fluctuations total score, CAMCOG Cambridge Cognitive Examination, Duration dura-
tion of cognitive symptoms in years, HC healthy controls, LBD Lewy body dementia, Mayo cogn Mayo 
Fluctuations Cognitive Subscale, Mayo total, Mayo Fluctuations Scale, Mayo arousal Mayo Fluctuations 
Arousal Subscale, MMSE Mini Mental State Examination, na not applicable, PD meds number of patients 
taking dopaminergic medication, UPDRS Unified Parkinson’s Disease Rating Scale III, NPI Neuropsychi-
atric Inventory, NPI hall NPI Hallucination Subscore
a Chi-square test HC, AD, DLB
b One-way ANOVA HC, AD, DLB
c Chi-square test AD, DLB
d Mann–Whitney U test AD, DLB
e Student’s t test AD, DLB
f N = 27
HC (N = 22) AD (N = 28) LBD (N = 39) Between-group differences
Male:female 15:7 22:6 34:5 χ2 = 3.18, p = 0.20a
Age 75.9 (5.4) 76.6 (8.1) 75.5 (5.5) F2,86 = 0.22, p = 0.80b
AChEI na 26 35 χ2 = 0.19, p = 0.66c
PD meds na 0 28 χ2 = 34.54, p < 0.001c
Duration na 3.9 (2.1) 3.0 (1.9) U = 395, p = 0.05d
MMSE 29.2 (0.9) 21.8 (3.1) 23.5 (3.7) t65 = 1.94, p = 0.06e
CAMCOG 96.7 (3.7) 71.0 (11.5) 76.2 (12.5) t65 = 1.73, p = 0.09e
UPDRS 1.1 (1.4) 2.1 (2.0) 19.2 (8.4) t65 = 10.47, p < 0.001e
CAF total na 0.7 (1.7)f 5.0 (4.7) t64 = 4.46, p < 0.001e
Mayo total na 8.8 (4.0)f 13.2 (5.9) t64 = 3.39, p = 0.001e
Mayo cogn na 1.8 (1.8)f 2.7 (1.9) t64 = 1.96, p = 0.05e
NPI total na 6.9 (6.4)f 13.3 (10.4) t64 = 2.89, p = 0.005e
NPI hall na 0.04 (0.2)f 1.7 (2.1) t64 = 4.14, p < 0.001e
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fluctuations, and were more often on dopaminergic medi-
cation than DLB patients.
The number of recorded trials did not differ between 
the three groups (mean HC = 301.1, mean AD = 295.7, 
mean LBD =  302.8; Kruskal–Wallis ANOVA, F2 = 1.07, 
p = 0.59). The percentage of correct trials was higher in 
the control group than in the AD and the LBD group, 
but did not significantly differ between the two demen-
tia groups (mean HC = 98%, mean AD = 90%, mean 
LBD = 85%; Kruskal–Wallis test, F2 = 33.04, p < 0.001; 
post hoc Dunn’s test, p (HC, AD) < 0.001, p (HC, 
LBD) < 0.001, p (AD, LBD) = 0.27).
Comparison of ex‑Gaussian parameters
Mu was significantly increased in the LBD group compared 
to both controls and AD while there was no significant dif-
ference in mu between controls and AD. The same effect 
was observed for sigma. Tau was significantly increased in 
both dementia groups compared to controls, but there was 
no significant difference in tau between the two dementia 
groups (see Fig. 2 and Table 2). These results persisted when 
analyzing matched dementia subgroups (see Supplementary 
Table S3).
Supplementary Table S4 shows a comparison of ex-
Gaussian parameters when DLB and PDD were treated as 
separate groups. Overall, the PDD group seemed to be more 
Fig. 2  a Comparison of ex-
Gaussian parameters between 
HC, AD, and LBD, see Table 2 
for more detailed statistics. b 
Fitted ex-Gaussian distributions 
for mean parameters within 
each group (thick lines) and for 
each individual participant (thin 
lines)
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impaired than the DLB group (higher mu, sigma, and tau); 
however, none of the differences between DLB and PDD 
were significant after correcting for multiple comparisons.
Correlations with clinical scores in the dementia 
groups
In the LBD group, there was a significant positive correla-
tion between the percentage of correct responses and the 
MMSE (see Table 3). There was also a trend for a positive 
correlation between the UPDRS and mu and sigma. How-
ever, this correlation did not survive correction for multiple 
comparisons. There was no significant correlation between 
any of the ex-Gaussian parameters and any clinical fluctua-
tions score (see Table 3 and Supplementary Table S5).
In the AD group, mu and sigma were negatively corre-
lated with the MMSE. Furthermore, there was a trend for a 
negative correlation between MMSE and tau.
Correlations with grey and white matter volume 
in Lewy body dementia
Three DLB and two AD patients did not have structural 
MRI scans available and were, therefore, excluded from the 
VBM analysis. When comparing overall grey matter volume 
between the groups, AD and LBD showed decreases in grey 
matter volume compared to controls and these deficits were 
more pronounced in AD than in LBD (see Supplementary 
Figures S2–S4). There were no differences in grey matter 
volume between DLB and PDD.
In the LBD group, for correlations with grey matter vol-
ume, the minimum cluster sizes as estimated by 3dClust-
Sim in AFNI were 251 voxels for mu, 249 voxels for 
sigma, and 236 voxels for tau. For correlations with white 
matter volume, the estimated minimum cluster sizes were 
314 voxels for mu and 304 voxels for sigma. None of the 
grey or white matter clusters were large enough to survive 
this correction. They are, therefore, reported as an explora-
tory analysis at a voxel-level threshold of p < 0.001. When 
considering clusters with p < 0.001 (uncorrected), mu was 
negatively correlated with grey matter volume in a cluster 
at the right lingual gyrus and frontal pole and with smaller 
clusters at the right paracingulate gyrus and thalamus (see 
Supplementary Table S6). Mu and sigma were both nega-
tively correlated with grey matter volume in the right sup-
plementary motor area. Furthermore, sigma was negatively 
correlated with bilateral frontal and subcortical regions 
(left and right thalamus, bilateral basal ganglia, and right 
amygdala), right temporal pole, and precuneus. Tau was 
positively correlated with grey matter volume in the bilat-
eral cerebellum and the left frontal pole.
At an uncorrected voxel-level threshold of p < 0.001, 
mu and sigma were both negatively correlated with white 
matter volume in frontal regions and around the primary 
motor cortices and supplementary motor areas (see Sup-
plementary Table S6). There were no significant correla-
tions between white matter volume and tau.
Table 2  Ex-Gaussian parameters, mean (standard deviation)
Between-group differences were assessed by Kruskal–Wallis ANOVA with Dunn’s post hoc tests, p values are Bonferroni-corrected for multiple 
comparisons
AD Alzheimer’s disease, HC healthy controls, LBD Lewy body dementia
HC AD LBD Kruskal–Wallis Post hoc tests
HC vs. AD HC vs. LBD AD vs. LBD
Mu 649.43 (73.88) 748.90 (139.38) 930.73 (166.22) F2 = 40.49, p < 0.001 p = 0.06 p < 0.001 p < 0.001
Sigma 59.85 (22.87) 78.57 (46.98) 125.03 (62.75) F2 = 23.25, p < 0.001 p = 0.88 p < 0.001 p = 0.001
Tau 313.48 (119.50) 523.28 (202.89) 572.99 (213.21) F2 = 24.16, p < 0.001 p < 0.001 p < 0.001 p = 1.00
Table 3  Spearman’s rank 
correlations of Ex-Gaussian 
parameters and overall 
performance with clinical 
scores in the LBD and AD 
groups separately, correlation 
coefficient (p value, FDR 
corrected for multiple 
comparisons)
Mayo cogn Mayo Fluctuations Cognitive Subscale, MMSE Mini Mental State Examination, UPDRS Uni-
fied Parkinson’s Disease Rating Scale III, % Correct percentage of correct trials across all included runs
LBD AD
Mayo cogn UPDRS MMSE MMSE
Mu 0.31 (0.11) 0.34 (0.09) − 0.10 (0.57) − 0.59 (0.007)
Sigma 0.29 (0.11) 0.39 (0.06) 0.06 (0.72) − 0.52 (0.02)
Tau 0.32 (0.10) 0.23 (0.22) − 0.15 (0.46) − 0.42 (0.08)
% Correct − 0.15 (0.46) − 0.11 (0.57) 0.62 (0.0005) 0.35 (0.11)
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Correlations with grey and white matter volume 
in Alzheimer’s disease
In the AD group, for correlations with grey matter volume, 
the minimum cluster sizes as estimated by 3dClustSim in 
AFNI were 282 voxels for mu, 266 voxels for sigma, and 260 
voxels for tau. For correlations with white matter volume, 
the estimated minimum cluster sizes were 264 voxels for mu, 
279 voxels for sigma, and 283 voxels for tau.
At an uncorrected voxel-level threshold of p < 0.001, mu 
was negatively correlated with numerous clusters in wide-
spread parts of the brain including bilateral occipital, fron-
tal, and temporal cortices (see Fig. 3 and Supplementary 
Table S7). Two larger clusters in right frontal and left tem-
poral regions survived correction for multiple comparisons. 
Sigma was negatively correlated with grey matter volume in 
right frontal pole and left supramarginal gyrus (after correc-
tion for multiple comparisons), and smaller clusters in left 
temporal and frontal regions, and the precuneus. There was 
a positive correlation between sigma and grey matter volume 
in bilateral temporal gyri and the cerebellum. Tau was nega-
tively correlated with clusters in the right cerebellum.
There were two larger clusters of negative correlation 
between sigma and white matter volume in left temporal 
gyrus that survived multiple comparison correction (see 
Fig. 3 and Supplementary Table S7). At an uncorrected 
voxel-level threshold of p < 0.001, mu was negatively cor-
related with white matter volume in middle temporal regions 
and tau was negatively correlated with white matter volume 
in left lingual regions.
Discussion
In this study, we investigated changes in reaction time per-
formance in LBD and AD compared to healthy ageing using 
an ex-Gaussian distributional analysis. We observed differ-
ential effects for the different ex-Gaussian parameters indi-
cating that different aspects of reaction time distributions are 
differentially affected by the two forms of dementia. The two 
dementia groups could be distinguished by a relative lack of 
an overall reaction time slowing in the AD group compared 
to the LBD group. While dementia in general led to more 
fluctuations in reaction time performance as indicated by an 
increase in tau, this did not appear to be associated with the 
clinical fluctuations observed in LBD patients. We found 
widespread correlations between the Gaussian parameters 
and grey and white matter volume in AD, whereas there was 
a relative lack of significant results in the LBD patients with 
respect to correlations between reaction time performance 
and cortical volume.
More extremely slow responses in Alzheimer’s 
disease compared to controls
Results from a previous standard reaction time analysis in 
the same group of participants suggested a slowing of reac-
tion time performance in both dementia groups as indicated 
by an increased mean reaction time with more pronounced 
deficits in LBD compared to AD [24]. The present ex-
Gaussian distributional analysis allows for a more detailed 
and specific characterization of reaction time performance 
changes in dementia. The lack of a significant increase in 
the mean of the Gaussian component in AD compared to 
controls indicates that there is no major overall slowing of 
reaction times in our AD group compared to healthy ageing, 
contrary to what was suggested by the results of the stand-
ard reaction time analysis using arithmetic mean reaction 
times. In contrast, the increased tau parameter shows that 
the overall increase in mean reaction time in AD patients 
is being driven by an increase in extremely slow responses. 
These can be seen as temporary attentional lapses in a sub-
set of trials and are thought to be more directly linked to 
T
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(b) Alzheimer's disease, GM, negative correlation, sigma
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Fig. 3  Correlations between ex-Gaussian parameters and grey mat-
ter (GM) and white matter (WM) volume for contrasts with clusters 
that survived multiple comparison correction. Clusters of significant 
correlations are overlaid on the MNI standard brain in radiological 
convention, i.e., the right side of the image corresponds to the left 
hemisphere. See Supplementary Tables S6 and S7 for all uncorrected 
clusters
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attentional difficulties than an overall slowing of reaction 
times [33]. It has also been argued that tau reflects more 
dynamic processes of attention such as attentional control 
and working memory; an increase in tau might thus reflect a 
breakdown of attentional control systems and poorer work-
ing memory capacities in AD [14, 15]. The present result is 
in line with previous studies that have consistently associ-
ated mild AD with an increase in tau and no change in mu 
or sigma across different tasks [13, 14]. The same has been 
reported in non-demented individuals who later converted 
to AD, suggesting that an increase in tau might be a very 
early indicator of the disease [34]. Our results show that the 
overall pattern observed in preclinical and early stage AD 
persists in patients at a mild to moderate stage of dementia. 
However, in addition to an increase in tau we also found a 
trend for a larger mu in AD compared to controls, indicating 
that a more general slowing of reaction times might develop 
in AD patients as the disease progresses. This hypothesis is 
supported by a negative correlation between mu and demen-
tia severity as measured by the MMSE, suggesting that more 
severe dementia is related to slower overall reaction times 
in the AD group.
Overall reaction time slowing in Lewy body 
dementia compared to Alzheimer’s disease 
and controls
This is the first ex-Gaussian study of reaction time distribu-
tions in LBD patients. In addition to the increase in exces-
sively slow responses that was observed in both demen-
tia groups, LBD patients also showed an overall slowing 
(increased mu) and higher variability (increased sigma) 
compared to controls. In addition, this slowing of reaction 
times was significantly larger than in the AD group and 
might be linked to greater attentional impairment in LBD 
relative to AD [6, 7]. However, we did not observe any dif-
ference between the two dementia groups with respect to the 
slow tail of the distribution (tau), i.e., there was no further 
increase in attentional lapses in LBD patients compared to 
AD. This is in contrast to our hypothesis given that tau is 
thought to capture attentional fluctuations [15] which are a 
core symptom of LBD and less common in AD [16]. How-
ever, the correlation analysis with the clinical fluctuation 
scales did not reveal any significant correlation between the 
severity of cognitive fluctuations and any of the ex-Gaussian 
parameters, suggesting that tau, contrary to our hypothesis, 
might not be a suitable marker for cognitive fluctuations in 
LBD. It also suggests that the fluctuations that are commonly 
observed in LBD patients and that are measured by clinical 
scales might not correspond well to trial-to-trial fluctua-
tions that are observed upon the execution of the ANT task. 
This is in contrast to early studies in DLB that found a posi-
tive relation between the severity of cognitive fluctuations 
and trial-to-trial fluctuations on choice reaction time tasks 
[8–10]. However, LBD patients in earlier studies were more 
impaired than the present LBD group and in contrast to most 
of our patients, they were not taking acetylcholinesterase 
inhibitors [8–10]. Cholinesterase inhibitors have been shown 
to reduce reaction time variability in patients with cogni-
tive fluctuations [35]. The discrepancy between the present 
results and previous studies could, therefore, indicate that 
the association between clinical fluctuation severity and 
trial-to-trial reaction time variability might be specific to 
unmedicated LBD patients.
We observed a correlation trend between the Gaussian 
parameters (mu and sigma) and the severity of Parkinson-
ism, suggesting that motor problems in LBD might have an 
influence on the general slowing of reaction time perfor-
mance [9]. This is supported by the fact that the PDD group 
which generally showed more severe motor impairment also 
seemed to be more impaired in terms of the ex-Gaussian 
parameters than the DLB patients. However, these differ-
ences did not remain significant after correcting for multiple 
comparisons.
Structural correlates of reaction time deficits 
in Lewy body dementia and Alzheimer’s disease
This is the first investigation assessing the association 
between ex-Gaussian parameters and cortical volume in 
LBD. We found more significant correlations between grey 
and white matter loss and reaction time deficits in AD than 
in LBD, indicating that attentional deficits in AD might be 
more strongly linked to regional brain volume than in LBD.
The AD group showed negative correlations between grey 
matter volume in widespread cortical regions, such as tem-
poral, lingual, and left frontal cortex, and the Gaussian part 
of the reaction time distribution (mu and sigma). Further-
more, white matter loss in temporal regions was related to 
increased sigma which corroborates the grey matter results. 
In contrast, white matter volume was not significantly related 
to mu which is in line with previous studies that have sug-
gested that reaction time variability might be more related 
to white matter changes than mean reaction time [36, 37]. 
Both mu and sigma also correlated with the MMSE, sug-
gesting that correlations between cortical volume and these 
ex-Gaussian parameters may be, at least partly, related to 
global cognition in AD. This is supported by the negative 
correlations between mu and sigma and grey matter volume 
at several brain regions related to the default mode network 
such as the occipital cortex, temporal gyrus, paracingulate 
cortex, frontal pole, and the precuneus [38]. The default 
mode network is a brain system associated with memory 
recall and is highly affected by AD pathology [39].
When considering results at an uncorrected threshold, 
our LBD group showed negative correlations in the frontal 
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cortex, specifically between the right frontal pole and reac-
tion time variability (sigma). This agrees with Sanchez-
Castaneda et al. [40] who reported a relation between a 
reduction in cortical volume within frontal regions and 
worse performance on a test of maintained attention and 
response inhibition in LBD. On the contrary, tau showed a 
positive correlation with left cerebellar Crus I. This region 
has been associated with the dorsal attention network [41] 
and has been found to be structurally altered in DLB [42]. 
The observed association of a higher number of very slow 
responses with an increase in grey matter volume might 
seem counter-intuitive. However, it may represent an imbal-
ance within the attention system, where a structurally intact 
cerebellum may drive an “over-thinking” in the decision 
making during the ANT task, causing higher values of tau. 
Although non-significant after multiple comparison correc-
tion these regions showed some correspondence with the 
results in the AD group. Many LBD cases, especially those 
with DLB, exhibit significant concurrent AD pathology [43, 
44] which has been related to higher global atrophy rates 
in these patients [45–47] and may explain some of these 
similarities.
However, the overall lack of significant VBM correlations 
in the LBD group suggests that attentional dysfunction in 
LBD might be more related to microstructural changes at 
the synaptic level that are not observable by volume estima-
tors such as VBM [48]. In line with this hypothesis, there 
is evidence that Lewy body pathology might play a role in 
disrupting the structure and function of synapses in LBD 
[49, 50].
Another possible explanation would be strategic neuronal 
loss in key widespread cortico-petal networks such as the 
cholinergic or noradrenergic systems which are profoundly 
pathological in LBD [51–54], but are difficult to discern in 
standard structural neuroimaging.
Limitations
The ANT was originally designed to probe three different 
aspects of attention by comparing reaction time performance 
between the different cue and target conditions (alerting 
effect: no cue—neutral cue, orienting effect: neutral cue-
spatial cue, executive conflict effect: incongruent target—
congruent target [25]). In the present analysis we combined 
trials from all conditions and only considered overall effects 
on the three ex-Gaussian parameters. While the ex-Gaussian 
analysis provides a useful tool to separate different parts 
of the reaction time distribution, a problematic aspect is 
its need for a relatively high number of trials to obtain a 
good model fit. The low number of trials that was avail-
able for each cue and target condition did not allow for a 
successful fit of the ex-Gaussian distribution to each con-
dition separately. Therefore, it was not feasible to perform 
the ex-Gaussian analysis for the different components of the 
ANT. Future studies with a larger number of trials will be 
needed to study the effect of the different ANT conditions 
on the three ex-Gaussian parameters.
Conclusions
This study shows that different aspects of reaction time per-
formance are differentially affected by AD and LBD. Fur-
thermore, we showed that the neural correlates of impaired 
attentional performance differ between the two forms of 
dementia. While impaired reaction time performance is 
linked to grey and white matter atrophy in AD, the more 
pronounced behavioural deficits that we observed in the 
LBD group did not exhibit strong correlations with brain 
structure. They, therefore, seem to be a functional or micro-
structural rather than a macrostructural phenomenon. How-
ever, future work using functional MRI or diffusion tensor 
imaging will be required to further elucidate this.
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